The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cost differential among systemic therapies for colon cancer.
Hasan Nadeem
No relevant relationships to disclose
Thejus T. Jayakrishnan
No relevant relationships to disclose
T. Clark Gamblin
No relevant relationships to disclose
Kiran Turaga
No relevant relationships to disclose